bullish

XWELL

Reviewing the Biosurveillance Opportunity with Ezra Ernst, CEO of the XpresCheck Division

684 Views21 Dec 2022 08:00
Issuer-paid
KEY POINTS The XpresCheck Division of XWELL is now focused on conducting a biosurveillance program under a contract with the CDC at five US...
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only)
Discussions
(Paid Plans Only)
chart-bar
Logo
Water Tower Research
Research from Water Tower Research
Water Tower Research
Equity Bottom-UpThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
  • Reviewing the Biosurveillance Opportunity with Ezra Ernst, CEO of the XpresCheck Division
    21 Dec 2022
x